"Broken-hearted" isn't just a metaphor -- social pain and physical pain have a lot in common, according to Naomi Eisenberger of the University of Califiornia-Los Angeles, the author of a new paper published in Current Directions ...
Feb 22, 2012
0
2
Men all over the world are suffering from deteriorating semen quality—often referred to as an outright fertility crisis.
May 23, 2022
0
28
A clinical trial assessing the potential of the nutritional supplement inosine to treat Parkinson disease has found that the studied dosages successfully raised participants' levels of the antioxidant urate without producing ...
Dec 23, 2013
0
0
A repurposed arthritis drug has shown positive results in a clinical trial of patients hospitalized with COVID-19, according to a paper published Wednesday in the New England Journal of Medicine.
Jun 17, 2021
0
7
(HealthDay)—For patients with Behçet's syndrome, the oral phosphodiesterase-4 inhibitor apremilast is effective for treating oral ulcers, according to a study published in the April 16 issue of the New England Journal ...
Apr 17, 2015
0
1
Results of a recently completed clinical trial of a potential drug to treat Type 2 diabetes in children were announced Sunday [April 28] at the Pediatric Academic Societies 2019 meeting in Baltimore, Md. The New England Journal ...
Apr 29, 2019
0
121
The steady rise in the use of cannabis—18 states have legalized recreational use, 13 have decriminalized its use and 36 have medical cannabis laws—has provoked myriad questions and concerns about public health implications, ...
Jan 31, 2022
2
124
New research shows that chondroitin sulfate significantly decreased pain and improved hand function in patients with osteoarthritis (OA) of the hand compared with those in the placebo group. Results of the clinical trial ...
Sep 6, 2011
0
0
Among patients with the systemic autoimmune disease primary Sjögren syndrome, use of hydroxychloroquine, the most frequently prescribed treatment for the disorder, did not improve symptoms during 24 weeks of treatment compared ...
Jul 15, 2014
0
0
The monoclonal antibodies cinpanemab and prasinezumab show almost no benefit for early Parkinson disease, according to two phase 2 trials published in the Aug. 4 issue of the New England Journal of Medicine.
Aug 4, 2022
0
2
